Drug Database
Back to search

United States· US:0832-0285_0392c67b-a83c-4e6c-95d6-09604953652d

Bexarotene

A bexarotene product containing bexarotene, registered in United States by Upsher-Smith Laboratories, Inc.. The same ATC class is registered in 13 of our 19 countries.

ATC L01XF03US label

Checked against FDA National Drug Code directory (United States) on

Informational only — not a medical device.

SOURCE REGISTER · USFDA National Drug Code directory (Unite…normalisedBexaroteneATCL01XF03REGISTER NO.US:0832-0285_0392c67b…PACKS LISTED2CHECKEDSeptember 27, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about bexaroteneAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Bexarotene is registered in 13 of 19 countries.

Countries holding a registration under ATC L01XF03 (bexarotene), each read from that country’s own register.

  • This record: United States, from FDA National Drug Code directory (United States)
  • 8 of them publish a price we can compare per daily dose
Search bexarotene products by name

Bexarotene · ATC L01XF03

13 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Germany
  • Icelandprice
  • Italyprice
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FDA National Drug Code directory (United States)
Active substance
BEXAROTENE
Manufacturer
Upsher-Smith Laboratories, Inc.
Country
United States (US)
ATC code
L01XF03
ATC class
Bexarotene
Defined daily dose
0.54 g, O
Reimbursed
Not published by this register
Source register
FDA National Drug Code directory (United States)
Last checked
September 27, 2026

Packs & prices · 2

  • ndc11
    0832028500
    100 CAPSULE in 1 BOTTLE (0832-0285-00)
  • ndc11
    0832-0285-00

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

573 interactions on record for bexarotene.

Graded by severity as the source publishes them — 127 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check bexarotene against other medicinesHow interaction checks work

Bexarotene · interactions on record

573 records

  • 127 severe
  • 357 moderate
  • 80 minor
  • 9 info

Most severe, free to view

  • EluxadolineA07DA06severe
  • LiraglutidA08AX02severe
  • SemaglutidA08AX03severe
  • SitagliptinA10BH01severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Bexarotene in 14 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All bexarotene products

Authorised across Europe · EMA

The same active substance is authorised in 12 EEA countries. Names it is sold under:

  • Austria · Bexagia
  • Germany · Bexaroten Cipla
  • Denmark · Bexarotene
  • Spain · Bexaroteno Cipla
  • Finland · Bexarotene Amdipharm
  • France · Bexarotene Cipla
  • United Kingdom (Northern Ireland) · Bexarotene Genus Pharmaceuticals Ltd.
  • Iceland · Targretin
  • Italy · Bexarotene Cipla
  • Liechtenstein · Targretin
  • Norway · Bexarotene Amdipharm, Targretin
  • Sweden · Bexarotene Amdipharm

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/e2f51be7-b6b2-4d6e-9334-f85b563440f4
GET /v1/drugs/e2f51be7-b6b2-4d6e-9334-f85b563440f4?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "route": "ORAL",
  "source": "ndc",
  "strength": "75",
  "substance": "BEXAROTENE",
  "productndc": "0832-0285",
  "dosage_form": "CAPSULE",
  "dea_schedule": null,
  "strength_unit": "mg/1",
  "application_number": "ANDA209886",
  "marketing_category": "ANDA"
}
API referenceMCP serverPlans

See everything about bexarotene.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console